GLP-2 / GLP-3
GLP-2 / GLP-3, 10mg / 10mg. Two multi-receptor incretin research compounds, 10 mg each. 99%+ HPLC, COA per lot. Research use only.
Select Vial Specification:- ISO/IEC 17025 independent lab tested (HPLC & Mass Spectrometry)
- Scannable QR code on every vial linking directly to lot COA
- Complimentary MBP-H2O reconstitution water included
- Same-day tracked dispatch on orders placed before 2:00 PM EST
Research Description
This is a blend. GLP-2 and GLP-3 are combined in a single 20 mg vial, 10 mg of each. Both are multi-receptor incretin research compounds studied in metabolic models. GLP-2 is characterised at the GIP and GLP-1 receptors; GLP-3 adds glucagon-receptor activity to the same pair. Combining them in one vial is a formulation convenience for comparative work; the combination itself has not been characterised as a single entity.
GLP-2 is characterised as a co-agonist at the GIP and GLP-1 receptors. Insulinotropic signalling and gastric-emptying endpoints are the measured readouts in preclinical models.
GLP-3 adds glucagon-receptor agonism to the GIP/GLP-1 pair. Energy-expenditure and hepatic-lipid endpoints are characterised alongside the incretin readouts.
Storage & Handling Protocol
Store lyophilized vials at −20 °C for long-term stability (up to 24 months) or 2–8 °C for short-term laboratory protocols. Protect from direct light and moisture. Strictly for in-vitro laboratory research use only.
Quality & Lot Specifications
| Compound | GLP-2 / GLP-3 |
| Category | Peptide Blends |
| Lot Number | MBP-9827 → |
| Purity (RP-HPLC) | ≥ 99.0% (Verified) |
| Identity | Confirmed via ESI-MS |
| Endotoxin Screen | < 0.5 EU/mg (LAL Assay) |
| Physical Form | Lyophilized powder (No fillers) |
| Storage Temp | −20 °C Long-Term |
Customer Reviews
No reviews yet — click '+ Write a Review' to share your experience!